INDEGENE
|
INDEGENE Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹48 Cr | ₹44 Cr | ₹44 Cr | ₹0.35 Cr | ₹0.31 Cr |
| Equity - Authorised | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹0.50 Cr | ₹0.50 Cr |
| Equity - Issued | ₹48 Cr | ₹44 Cr | ₹44 Cr | ₹0.35 Cr | ₹0.31 Cr |
| Equity Paid Up | ₹48 Cr | ₹44 Cr | ₹44 Cr | ₹0.35 Cr | ₹0.31 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | ₹36 Cr | ₹31 Cr | ₹18 Cr | ₹5.76 Cr | ₹4.41 Cr |
| Total Reserves | ₹2,532 Cr | ₹1,353 Cr | ₹1,002 Cr | ₹758 Cr | ₹320 Cr |
| Securities Premium | ₹993 Cr | ₹247 Cr | ₹240 Cr | ₹281 Cr | ₹16 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹1,478 Cr | ₹1,073 Cr | ₹736 Cr | ₹469 Cr | ₹300 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | ₹61 Cr | ₹34 Cr | ₹26 Cr | ₹7.91 Cr | ₹3.26 Cr |
| Reserve excluding Revaluation Reserve | ₹2,532 Cr | ₹1,353 Cr | ₹1,002 Cr | ₹758 Cr | ₹320 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹2,616 Cr | ₹1,429 Cr | ₹1,064 Cr | ₹764 Cr | ₹325 Cr |
| Minority Interest | - | - | - | - | ₹8.58 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | ₹333 Cr | ₹394 Cr | ₹11 Cr | ₹18 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | ₹393 Cr | ₹394 Cr | ₹18 Cr | ₹25 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | ₹-60 Cr | - | ₹-7.30 Cr | ₹-7.08 Cr |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-90 Cr | ₹-71 Cr | ₹-67 Cr | ₹-69 Cr | ₹-37 Cr |
| Deferred Tax Assets | ₹90 Cr | ₹75 Cr | ₹70 Cr | ₹78 Cr | ₹38 Cr |
| Deferred Tax Liability | - | ₹4.10 Cr | ₹3.00 Cr | ₹8.54 Cr | ₹1.66 Cr |
| Other Long Term Liabilities | ₹87 Cr | ₹129 Cr | ₹222 Cr | ₹112 Cr | ₹34 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹59 Cr | ₹43 Cr | ₹35 Cr | ₹26 Cr | ₹12 Cr |
| Total Non-Current Liabilities | ₹56 Cr | ₹435 Cr | ₹584 Cr | ₹80 Cr | ₹27 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹93 Cr | ₹118 Cr | ₹73 Cr | ₹74 Cr | ₹50 Cr |
| Sundry Creditors | ₹93 Cr | ₹118 Cr | ₹73 Cr | ₹74 Cr | ₹50 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹395 Cr | ₹403 Cr | ₹354 Cr | ₹305 Cr | ₹128 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹199 Cr | ₹132 Cr | ₹109 Cr | ₹187 Cr | ₹56 Cr |
| Interest Accrued But Not Due | - | ₹2.60 Cr | ₹0.30 Cr | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹196 Cr | ₹268 Cr | ₹245 Cr | ₹118 Cr | ₹72 Cr |
| Short Term Borrowings | - | ₹9.70 Cr | - | - | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | ₹9.70 Cr | - | - | - |
| Short Term Provisions | ₹76 Cr | ₹81 Cr | ₹62 Cr | ₹61 Cr | ₹21 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹8.10 Cr | ₹13 Cr | ₹12 Cr | ₹25 Cr | - |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹68 Cr | ₹68 Cr | ₹50 Cr | ₹35 Cr | ₹21 Cr |
| Total Current Liabilities | ₹565 Cr | ₹611 Cr | ₹489 Cr | ₹440 Cr | ₹199 Cr |
| Total Liabilities | ₹3,236 Cr | ₹2,475 Cr | ₹2,137 Cr | ₹1,284 Cr | ₹559 Cr |
| ASSETS | |||||
| Gross Block | ₹1,096 Cr | ₹995 Cr | ₹863 Cr | ₹271 Cr | ₹191 Cr |
| Less: Accumulated Depreciation | ₹418 Cr | ₹349 Cr | ₹199 Cr | ₹134 Cr | ₹105 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹678 Cr | ₹646 Cr | ₹664 Cr | ₹138 Cr | ₹86 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹3.60 Cr | - | - | - | - |
| Non Current Investments | - | - | - | - | - |
| Long Term Investment | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Long Term Loans & Advances | ₹22 Cr | ₹35 Cr | ₹20 Cr | ₹16 Cr | ₹14 Cr |
| Other Non Current Assets | ₹2.50 Cr | ₹3.20 Cr | ₹3.70 Cr | ₹0.08 Cr | ₹0.06 Cr |
| Total Non-Current Assets | ₹706 Cr | ₹684 Cr | ₹688 Cr | ₹154 Cr | ₹100 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹1,290 Cr | ₹797 Cr | ₹614 Cr | ₹120 Cr | - |
| Quoted | ₹257 Cr | ₹290 Cr | ₹445 Cr | - | - |
| Unquoted | ₹1,033 Cr | ₹507 Cr | ₹169 Cr | ₹120 Cr | - |
| Inventories | - | - | - | - | - |
| Raw Materials | - | - | - | - | - |
| Work-in Progress | - | - | - | - | - |
| Finished Goods | - | - | - | - | - |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹751 Cr | ₹648 Cr | ₹642 Cr | ₹444 Cr | ₹285 Cr |
| Debtors more than Six months | ₹3.40 Cr | ₹3.00 Cr | ₹3.90 Cr | ₹3.29 Cr | ₹1.13 Cr |
| Debtors Others | ₹752 Cr | ₹647 Cr | ₹647 Cr | ₹446 Cr | ₹286 Cr |
| Cash and Bank | ₹375 Cr | ₹191 Cr | ₹86 Cr | ₹517 Cr | ₹140 Cr |
| Cash in hand | - | - | - | ₹0.01 Cr | ₹0.01 Cr |
| Balances at Bank | ₹375 Cr | ₹191 Cr | ₹86 Cr | ₹517 Cr | ₹140 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹54 Cr | ₹121 Cr | ₹71 Cr | ₹42 Cr | ₹33 Cr |
| Interest accrued on Investments | - | - | - | - | ₹0.04 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | ₹6.90 Cr | ₹6.00 Cr | ₹3.10 Cr | - | - |
| Prepaid Expenses | ₹47 Cr | ₹74 Cr | ₹41 Cr | ₹34 Cr | ₹26 Cr |
| Other current_assets | - | ₹42 Cr | ₹27 Cr | ₹8.25 Cr | ₹7.77 Cr |
| Short Term Loans and Advances | ₹60 Cr | ₹34 Cr | ₹36 Cr | ₹6.46 Cr | ₹0.65 Cr |
| Advances recoverable in cash or in kind | ₹22 Cr | ₹15 Cr | ₹19 Cr | ₹4.68 Cr | ₹0.65 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹38 Cr | ₹19 Cr | ₹17 Cr | ₹1.77 Cr | - |
| Total Current Assets | ₹2,530 Cr | ₹1,791 Cr | ₹1,449 Cr | ₹1,130 Cr | ₹459 Cr |
| Net Current Assets (Including Current Investments) | ₹1,966 Cr | ₹1,180 Cr | ₹960 Cr | ₹690 Cr | ₹260 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹3,236 Cr | ₹2,475 Cr | ₹2,137 Cr | ₹1,284 Cr | ₹559 Cr |
| Contingent Liabilities | - | ₹0.70 Cr | ₹10 Cr | ₹0.50 Cr | ₹0.50 Cr |
| Total Debt | - | ₹403 Cr | ₹394 Cr | ₹18 Cr | ₹25 Cr |
| Book Value | 107.70 | 62.96 | 47.22 | 4,319.87 | 2,045.39 |
| Adjusted Book Value | 107.70 | 62.96 | 47.22 | 34.28 | 16.23 |
Compare Balance Sheet of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹12,245.1 Cr | 0.3% | -8.1% | -21.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 0.3% |
-8.1% |
-21.1% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses